Apogee Therapeutics, Inc. Common Stock (APGE) — Working Capital to Net Assets Ratio
Apogee Therapeutics, Inc. Common Stock (APGE) has a Working Capital to Net Assets ratio of 82.9% as of March 2026. Working capital of $1.04 Billion (current assets of $1.07 Billion minus current liabilities of $32.95 Million) is measured against net assets of $1.26 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See APGE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apogee Therapeutics, Inc. Common Stock Working Capital to Net Assets (2022–2025)
This chart shows how Apogee Therapeutics, Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 82.9%, reflecting working capital of $1.04 Billion against net assets of $1.26 Billion USD. See APGE cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Apogee Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apogee Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Apogee Therapeutics, Inc. Common Stock (APGE) market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 78.9% | $713.45 Million | $903.88 Million | $741.36 Million | $27.91 Million | ▲ +9.0 pp |
| 2024 | 69.9% | $501.15 Million | $716.79 Million | $529.71 Million | $28.56 Million | ▼ -29.5 pp |
| 2023 | 99.5% | $377.85 Million | $379.91 Million | $398.41 Million | $20.56 Million | ▼ -0.5 pp |
| 2022 | 100.0% | $142.07 Million | $142.07 Million | $152.06 Million | $9.98 Million | — |